These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15606388)

  • 41. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural history of chronic hepatitis C.
    Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
    Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus and death risk in hemodialysis patients.
    Kalantar-Zadeh K; Kilpatrick RD; McAllister CJ; Miller LG; Daar ES; Gjertson DW; Kopple JD; Greenland S
    J Am Soc Nephrol; 2007 May; 18(5):1584-93. PubMed ID: 17429053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Viral C hepatitis in patients with end stage renal disease. II. Viral genotypes].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(5):491-6. PubMed ID: 11195176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
    Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
    N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study.
    Monica F; Lirussi F; Pregun I; Vasile F; Fabris L; Okolicsanyi L
    Dig Liver Dis; 2006 May; 38(5):336-40. PubMed ID: 16627021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients.
    Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L
    Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
    Fabrizi F; Messa P
    G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B and hepatitis C virus and chronic kidney disease.
    Fabrizi F; Martin P; Messa P
    Acta Gastroenterol Belg; 2010; 73(4):465-71. PubMed ID: 21299156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
    Yu L; Morishima C; Ioannou GN
    Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Fabrizi F; Verdesca S; Messa P; Martin P
    Dig Dis Sci; 2015 Dec; 60(12):3801-13. PubMed ID: 26195311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.
    Hwang SJ; Yang WC; Lin MY; Mau LW; Chen HC;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2616-24. PubMed ID: 20519231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
    Lee JE; Lim JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kwon E; Kim HJ; Park JM; Jung HY; Choi JY; Park SH; Kim CD; Cho JH; Kim YL;
    PLoS One; 2017; 12(10):e0185853. PubMed ID: 28973026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.